New report shows high-voltage growth for Global Influenza Vaccines Market

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.

“Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019 – 2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.

Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.

Further, prudent analysis has been done on the competitor’s part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech and VaxInnate are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.

The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.

The major and emerging companies dominating this market for its vaccines, services and continuous product developments are:

Sanofi Pasteur
GlaxoSmithKline (GSK)
Seqirus (CSL Limited)
AstraZeneca
Mylan
Sinovac Biotech Ltd.
Gamma Vaccines Pty Ltd.
Hualan Biological Engineering Inc.
Shanghai Institute of Biological Products Co., Ltd.
Novavax
Daiichi–Sankyo
Mitsubishi Tanabe Pharma
BiondVax Pharmaceuticals Ltd
Altimmune
FluGen
Moderna
Vaccitech
VaxInnate

Twenty-One Major Markets(21MM) covered in the report are as follows:

United States
Canada
Germany
France
Italy
Spain
United Kingdom
Netherlands
Sweden
Denmark
Poland
Norway
Finland
Ireland
Belgium
Australia
New Zealand
Japan
Brazil
China
India

The Latest Industry Data Included in this Report:

Global Influenza Vaccines Market Size and Analysis (2013 – 2025)
Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025)
Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 – 2025)
Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 – 2025)
Rapid Diagnostic Testing for the Management of Influenza
Global Distribution Channel and Technique of Influenza Vaccination
Promising Influenza Vaccines in Clinical Development
Major Deals in the Global Influenza Vaccines Market
Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development

The Report Answers the Following Questions about the Global Influenza Vaccines Market:

How has the global influenza vaccines market performed so far and how will it perform in the coming years?
What are the key markets in the global influenza vaccines industry?
How many numbers of persons being vaccinated with influenza vaccines globally during 2013 – 2025?
What are the key drivers and inhibitors in the current market?
What are the various influenza vaccines available globally?
How is the market predicted to develop in the future?
Who are the key players in this market space?

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report @ dpiresearch.com/reports/influenza-vaccines-market-global-…

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Maria Rai
Sales Manager
Call: +91 766 764 8693
Email: sales@dpiresearch.com
Website: dpiresearch.com
Full Address:
Mehrauli, New Delhi,India,110030

China Proton Therapy Market Size, Status and Forecast to 2025

“China Proton Therapy Market Size, Status and Forecast to 2025” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in China. The research includes historic data from 2015 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. The report provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.The report further sheds light on the number of treatment rooms,current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at China proton therapy centers from 2008 to 2016.

The report also includes assessment of China reimbursement scenario; proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the China proton therapy market.

The report concludes with the profiles of major players in the China proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, China proton therapy centers developed by the companies and recent development of the proton therapy market.

The major companies dominating this market for its products, services and continuous product developments are:

Advanced Oncotherapy, Siemens Healthneers, ProNova Solution, ProTom International, Hitachi, Ion Beam Applications (IBA), Varian Medical Systems, Mevion Medical Systems

Long–term Growth Projection:

China represents a significant opportunity in the Global proton therapy market

China proton therapy market will exhibit a steady CAGR of over 30% by 2025

The potential China proton therapy market is likely to reach more than USD 10 Billion by 2025

IBA accounted highest number of proton therapy centers in the forecast period

Advanced Oncotherapy is emerging with novel technology and significantly impacting the proton

therapy market size over the forecast period

The Latest Industry Data Included in this Report:

Proton Therapy Current Applications

Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy

Proton Therapy Competitive Analysis by Company

China Proton Therapy Market Size & Analysis (2015 – 2025)

China Proton Therapy Market Opportunity Assessment (2012 – 2025)

China Number of Treatment Rooms and Forecast (2017 – 2025)

China Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator

China Number of Patients Treated at Proton Therapy Centers (2008 – 2016)

China Proton Therapy Reimbursement Scenario

Proton Therapy Center Component Analysis

Proton Therapy Clinical Trail Insight by Phase, Institute & Country

Major Deals in Proton Therapy Market

Key Market Drivers and Inhibitors of the China Proton Therapy Market

Major Companies Analysis

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market

Trending factors influencing the market of the China proton therapy market

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides a seven-year forecast which helps to provide a long-term assessment of developments in the China proton therapy market

Identification and analysis of the macro and micro factors that affect the China proton therapy market

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities

A comprehensive list of key market players along with the analysis of their current product portfolios and recent development

Neurovascular Devices Market

Global Neurovascular Devices market is set to touch US$ 5 Billion by 2025.

 

Market growth can be attributed to factors such as growing obese and ageing population, rising patient pool for hemorrhagic and ischemic stroke, ongoing product development & commercialization, increasing demand for minimally invasive procedures for the treatment of neurovascular disease, expansion of healthcare infrastructure across emerging markets and technological advancement in the field of neurovascular devices market.

 “Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 – 2017) and Future Forecast (2018 – 2025)” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the global neurovascular devices market.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as products, therapeutic application, geography, company and competitive landscape. A comprehensive analysis has been done on market share of all the categories. The report also includes assessment of competitive landscape analysis by companies. Key trends in terms of merger & acquisitions are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the neurovascular devices market.

The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2013 to 2017 and forecasts to 2025.

The report concludes with the profiles of major players in the neurovascular devices market. The major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and recent development of the neurovascular devices market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Stryker, Medtronic, MicroVention Terumo, Cerenovus (Johnson n Johnson), Penumbra, Microport Scientific Corporation, Integer Holdings Corporation

Market Segmentation: Global Neurovascular Devices Market

The global neurovascular devices market is classified on the basis of product type, therapeutic application, geography and company

Neurovascular Devices Market, by Products

• Coil

• Carotid Stent

• Clot Removal

• Liquid Embolic

• Coil Assist Balloon

• Coil Assist Stent

• Flow Diverter Stent

• Micro wire/Catheter

• Other Products

Neurovascular Devices Market, by Therapeutic Application

• Aneurysm

• Intracranial Atherosclerotic Disease (ICAD)

• Ischemic Stroke

• Arteriovenous Malformation (AVM)

• Other Therapeutic Applications

Neurovascular Devices Market, by Country

• United States

• France

• Germany

• Italy

• Spain

• United Kingdom

• Japan

• China

• India

• Brazil

• Rest of the World (ROW)

Neurovascular Devices Market, by Company

 

• Stryker

• Medtronic

• MicroVention Terumo

• Cerenovus (Johnson n Johnson)

• Penumbra

• Microport Scientific Corporation

• Integer Holdings Corporation

Key questions answered in this research report:

 

• At what pace is the neurovascular devices market growing, globally? What will be growth

  trend in future?

• What are the key drivers and inhibitors in the current market? What will be the impact of drivers

  and inhibitors in the future?

• What is the country revenue and forecast breakdowns? Which are the major country revenue

   pockets for growth in the neurovascular devices market?

• What are the various application areas and how they are poised to grow?

• How is the market predicted to develop in the future?

• Who are the market players?

Diabetes Insulin Delivery Pens Market Research Report 2018

Diabetes Insulin Delivery Pen market will surpass US$ 14.4 Billion by 2025.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices.

 

“Diabetes Insulin Delivery Pens Market Research Report 2018” presents an in-depth assessment of the diabetes insulin delivery pen market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for diabetes insulin delivery pen market. The report includes historic data from 2011 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, insulin pen volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025.It also provides an all-round analysis of overall number of patients with diabetes and insulin users. A comprehensive analysis has been done on market share of diabetes insulin delivery pen segment and countries-based market. The report also explores detailed description of growth drivers and inhibitors of the diabetes insulin delivery pens market.

The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2011 to 2017 and forecasts to 2025.

The report concludes with the profiles of major players in the diabetes insulin delivery pens market. The key market players are evaluated on various parameters such as company overview, product portfolios and recent development of the diabetes insulin delivery pens market.

Market segment by Type, the product can be split into

• Reusable Insulin Pens

• Disposable Insulin Pens

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.

Major Countries Analyzed Under This Report are:

United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil

The Latest Industry Data Included in this Report:

• Diabetes Population in 10 major markets(10MM) 2011-2025

• Insulin Users Insights in 10 major markets(10MM) 2011 – 2025

• Total Diabetes Insulin Delivery Pen Users (Volume),2011 – 2025

• Reusable (Cartridge) Insulin Delivery Pen Users (Volume),2011 – 2025

• Prefilled (Disposable) Insulin Delivery Pen Users (Volume),2011 – 2025

• Total Diabetes Insulin Delivery Pen Market Size & Analysis (Value)2011-2025

• Reusable (Cartridge) Insulin Delivery Pen Market (Value),2011-2025

• Prefilled (Disposable) Insulin Delivery Pen Market (Value),2011-2025

• Total Diabetes Insulin Delivery Pen Market Share, By Users (%),2011 – 2025

• Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2011 – 2025

• Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 – 2025

• Total Diabetes Insulin Delivery Pen Market Share (%),2011 – 2025

• Reusable (Cartridge) Insulin Delivery Pen Market Share (%),2011 – 2025

• Prefilled (Disposable) Insulin Delivery Pen Market Share (%),2011 – 2025

• Diabetes Insulin Delivery Pen Market, By Geography (Volume and Value),2011 – 2025

• Market Definition for the Specified Topic Along with Identification of Key Drivers

  and Inhibitors for the Market

• A Comprehensive List of Key Market Players Along with the Analysis of their Current

  Product Portfolios and Recent Development

Reimbursement for NIPT test will revolutionize the market in the Forecast Period

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025. 

The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods.

“Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.

The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market.

Key Findings:

• United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market

• China NIPT test market is set to cross USD 400 Million by 2025

• Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market

• Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market

• Rising focus on Reimbursement for NIPT test will revolutionize the market

• Two–Child policy is likely to boost China NIPT market

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

 

Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics

Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are:

Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests

Major Countries Analyzed Under This Report are:

United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries.

The Latest Industry Data Included in this Report:

• Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)

• Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)

• Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)

• Market Share Analysis, by Test, 2014 – 2025 (%)

• Market Share Analysis, by Major Countries, 2014 – 2025 (%)

• Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025

• Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025

• Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test

• Major Deals in Global Non–Invasive Prenatal Testing Market

• Global Perspectives on Clinical Adoption of NIPT

• Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors

• Key Companies Analysis

China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.

The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 – 2025)

•Clinical Chemistry

• Immunoassay

•Molecular Testing

• Self–Monitoring of Blood Glucose (SMBG)

•Point of Care Testing (POCT)

•Hematology

•Coagulation

•Microbiology

• Genetic Testing

• Infectious Diagnostics

• Histology and Cytology

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

• Roche Diagnostics

• Abbott Laboratories

• Siemens Healthineers

• Sysmex Corporation

• Mindray Medical International Limited

• Beckman Coulter Inc

• Shanghai Fosun Pharmaceutical Group

• Thermo Fisher Scientific Inc

• Hologic Inc

• Qiagen

• Cepheid

• Bio-Rad Laboratories Inc

• Da An Gene Co. Ltd

• Shanghai Kehua Bio–Engineering Co. Ltd.

The Latest Industry Data Included in this Report:

• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)

• China In Vitro Diagnostics Market Dynamics

• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)

• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)

• China In Vitro Diagnostics Market, Company Share by Revenue, 2017

• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017

• Assessment of In Vitro Diagnostics Regulation in China

• Major Partnership Deals in China In Vitro Diagnostics Market

• Recent Developments in China In Vitro Diagnostics Market

• Overview of Key Companies in China In Vitro Diagnostics Market

China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology

Read More & Order @ http://www.dpiresearch.com/report-details.php?P_ID=131

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.

The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 – 2025)

•Clinical Chemistry

• Immunoassay

•Molecular Testing

• Self–Monitoring of Blood Glucose (SMBG)

•Point of Care Testing (POCT)

•Hematology

•Coagulation

•Microbiology

• Genetic Testing

• Infectious Diagnostics

• Histology and Cytology

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

• Roche Diagnostics

• Abbott Laboratories

• Siemens Healthineers

• Sysmex Corporation

• Mindray Medical International Limited

• Beckman Coulter Inc

• Shanghai Fosun Pharmaceutical Group

• Thermo Fisher Scientific Inc

• Hologic Inc

• Qiagen

• Cepheid

• Bio-Rad Laboratories Inc

• Da An Gene Co. Ltd

• Shanghai Kehua Bio–Engineering Co. Ltd.

The Latest Industry Data Included in this Report:

• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)

• China In Vitro Diagnostics Market Dynamics

• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)

• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)

• China In Vitro Diagnostics Market, Company Share by Revenue, 2017

• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017

• Assessment of In Vitro Diagnostics Regulation in China

• Major Partnership Deals in China In Vitro Diagnostics Market

• Recent Developments in China In Vitro Diagnostics Market

• Overview of Key Companies in China In Vitro Diagnostics Market

Germany Outbound Tourism Market: Outbound Tourists Visit, Tourists Spending & Forecast

Germany presents an attractive set of conditions making investment possible. Despite a Global recession, Germany has not been in bad shape in Germany outbound tourism market. The number of Germany outbound tourists is forecasted to reach nearly 5 Million by 2020. Additionally, Germany outbound tourists spending was nearly 11 Billion in 2015.

Germany Outbound Tourists Visit Analysis: United States has emerged as the most popular tourist destination for German travelers. In 2015, XXXX% of the total Germany outbound tourists visited United States. It is predicted that United States will be leading destination for the German travelers by the year 2020. China and Singapore were at the 2nd and 3rd popular destination for German travelers with XXX% and XXX% share respectively in 2015.

Germany Outbound Tourism Spending Analysis: United States is the leader with XXX% of spending in 2015 by the German Tourists. German tourists spending share in United States is higher than the combined share of the top 9 tourism destination. United States is likely to maintain dominance in Germany outbound tourism spending but its share is expected to tumble down to XXX% by the year 2020, as German tourists are now exploring various other destinations.  China and Australia accounted for XXX% and XXX% share of total outbound spending by Germany in 2015. It is projected that China and Australia will have spending share of XXX% and XXX% respectively in 2020. In the year 2015, India was standing at fourth spot in terms of spending by German tourists being followed by New Zealand in 2015.

DPI Researchreport entitled “Germany Outbound Tourism Market: Outbound Tourists Visit, Tourists Spending & Forecast”provides a comprehensive assessment of the fast-evolving, high-growth Germany outbound travel industry. This report provides a complete analysis of top 10 countries worldwide for German tourists. All the country in the report has been studied from three view points

1)    Germany outbound tourists to top 10 countries

2)    Germany outbound tourists market (spending) in top 10 countries

3)    Germany outbound tourists purpose of visit (Business, Holiday/Leisure, VFR & Others)

Countries Analysed

Top 10 Countries:Singapore, United States, Australia, China, Japan, South Africa, Korea, New Zealand, Cambodia and India

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources:Questionnaires, Surveys, telephonic interviews with industry experts and Observations

Secondary Sources:Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

Read More @ www.dpiresearch.com/report-details.php?P_ID=48

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. 

 

Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation

 

• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024

 

• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season

 

• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024

 

• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 –  2024)

• United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)

• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification

• Reimbursement & Regulatory System in the US Flu Vaccine Market

• Mergers, Acquisitions, Key Agreements & Collaborations

• Promising Flu Vaccine in Clinical Development

• Flu Vaccine Clinical Trial Insights by Phase, Company & Country

• Key Drivers and Inhibitors of the US Flu Vaccine Market

• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose

• Fluzone Quadrivalent

• Intradermal (ID) Trivalent

•Vaxigrip

• Fluarix Quadrivalent

• Flulaval Quadrivalent

• Flucelvax Quadrivalent

• Afluria Quadrivalent

• Agrippal

• Fluad

• Fluvirin

• Fluvax

Key Companies Covered in This Report:

• Seqirus

• Sanofi Pasteur

• GlaxoSmithKline(GSK)

Read More @ http://www.dpiresearch.com/report-details.php?P_ID=110

Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022

Read More and Order @ http://www.dpiresearch.com/report-details.php?P_ID=89

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in seasonal influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the seasonal influenza vaccine market such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook, and sales analysis of seasonal influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of seasonal influenza vaccine market.

Seven Major Markets(7MM) covered in the report are as follows:

1. United States

2. United Kingdom

3. France

4. Italy

5. Spain

6. Germany

7. Japan

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose

2. Fluzone Quadrivalent

3. Intradermal (ID) Trivalent

4. Vaxigrip

5. Fluarix Quadrivalent

6. Flulaval Quadrivalent

7. Fluenz Tetra

8. FluMist Quadrivalent

9. Flublok

10. VN–100

11. M–001

12. VAX–2012Q

13. TAK – 850

14. Flucelvax Quadrivalent

15. Afluria Quadrivalent

16. Agrippal

17. Fluad

18. Fluvirin

19. Fluvax

Seasonal Influenza Vaccine Report is segmented with 10 Chapters:

Chapter 1: Chapter one is the introduction with Executive Summary

Chapter 2: Chapter two provides overall recent and forecasts data for the seasonal influenza vaccine market in the top seven countries. This Chapter divided into 4 parts

1. Overall seasonal influenza vaccine market data from 2010 to 2022

2. Overall number of persons vaccinated with seasonal influenza vaccine data from 2010 to 2022

3. Seasonal influenza vaccine market share in the top seven countries data from 2010 to 2022

4. Persons being vaccinated with influenza vaccine share in the top seven countries data from 2010 to 2022

Chapter 3: Key market drivers and barriers in the seasonal influenza vaccine market.

Chapter 4: Chapter four gives detailed recent and forecasts for the seasonal influenza vaccine markets in the US, the UK, France, Italy, Spain, Germany and Japan, comprising of market size, total number of persons vaccinated, number of children vaccinated, number of 60+ years of age persons vaccinated, number of pregnant women vaccinated, number of chronic medical condition persons vaccinated, number of healthcare workers vaccinated and vaccination coverage.

Chapter 5: Chapter five gives detailed information on seasonal influenza vaccine production & distribution in United States. The information includes vaccine choices remain available for patients, providers, prices of a dose of vaccine, production, supply, and allocation by the major seasonal influenza vaccine manufacturers, seasonal influenza vaccine distribution & demand, seasonal influenza vaccine effectiveness, managing influenza with diagnostic resources, distribution method of seasonal influenza vaccination.

Chapter 6: Chapter six offers information about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU and Japan.

Chapter 7: Chapter seven highlights key M&A deals that took place in the seasonal influenza vaccine market between 2003 and 2015 and lists the major collaborations, licensing, exclusive and distribution agreements deals.

Chapter 8: Chapter eight provides detailed pipeline influenza vaccines in various companies’ pipelines with clinical development and early stage development vaccines.

Chapter 9: Chapter nine offers detailed information of the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase.

Chapter 10: Chapter ten gives information on the key players in the market with business overview, product outlook and sales analysis of the seasonal influenza vaccine.